Selected article for: "causative agent and hepatitis virus"
Author: Sandmann, Lisa; Ploss, Alexander
Title: Barriers of hepatitis C virus interspecies transmission
  • Cord-id: gd53s4dv
  • Document date: 2013_1_5
    • ID: gd53s4dv
    Snippet: Abstract Hepatitis C virus (HCV) is a major causative agent of severe liver disease including fibrosis, cirrhosis and liver cancer. Therapy has improved over the years, but continues to be associated with adverse side effects and variable success rates. Furthermore, a vaccine protecting against HCV infection remains elusive. Development of more effective intervention measures has been delayed by the lack of a suitable animal model. Naturally, HCV infects only humans and chimpanzees. The determin
    Document: Abstract Hepatitis C virus (HCV) is a major causative agent of severe liver disease including fibrosis, cirrhosis and liver cancer. Therapy has improved over the years, but continues to be associated with adverse side effects and variable success rates. Furthermore, a vaccine protecting against HCV infection remains elusive. Development of more effective intervention measures has been delayed by the lack of a suitable animal model. Naturally, HCV infects only humans and chimpanzees. The determinants of this limited host range are poorly understood in part due to difficulties of studying HCV in cell culture. Some progress has been made elucidating the barriers for the HCV lifecycle in non-permissive species which will help in the future to construct animal models for HCV infection, immunity and pathogenesis.

    Search related documents:
    Co phrase search for related documents
    • additional study and low density: 1
    • additional study and low density lipoprotein: 1
    • additional study and low frequency: 1
    • additional study and lysosomal degradation: 1
    • liver cirrhosis and low density: 1
    • liver cirrhosis and low density lipoprotein: 1
    • liver cirrhosis and low density lipoprotein receptor: 1
    • liver cirrhosis fibrosis and low density: 1
    • liver cirrhosis fibrosis and low density lipoprotein: 1
    • liver cirrhosis fibrosis and low density lipoprotein receptor: 1
    • liver disease and low activity: 1, 2, 3, 4
    • liver disease and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver disease and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • liver disease and lsecs liver sinusoidal endothelial cell: 1
    • liver disease and lymph node: 1, 2, 3
    • liver disease and lysosomal degradation: 1, 2